Skip to Main Content

Paper Details

Assessment of the impact of scheduled postmarketing safety summary analyses on regulatory actions.
Clin Pharmacol Ther
6
2016
Author NameAffiliation
Shohko SekineCenter for Drug Evaluation and Research
Shohko Sekine
Gerald J Dal PanCenter for Drug Evaluation and Research
  • 1 - 3

Datasets

Release 1.2